Drug Reference
influenza A virus (H3N2) antigen
Fact box
- Habit forming
- No
Brand names
Afluria 2024-2025Afluria 2025-2026Afluria Quadrivalent 2023-2024FluMist 2024-2025FluMist 2025-2026FluMist 2026-2027FluMist Quadrivalent 2023-2024Fluad 2024-2025Fluad 2025-2026Fluad 2026-2027Fluad Quadrivalent 2023-2024Fluarix 2024-2025Fluarix 2025-2026Fluarix 2026-2027Fluarix Quadrivalent 2023-2024Flublok 2024-2025Flublok 2025-2026Flublok 2026-2027Flublok Quadrivalent 2023-2024Flucelvax 2024-2025Flucelvax 2025-2026Flucelvax 2026-2027Flucelvax Quadrivalent 2023-2024Flulaval 2024-2025Flulaval 2025-2026Flulaval 2026-2027Flulaval Quadrivalent 2023-2024Fluzone 2024-2025Fluzone 2025 Southern HemisphereFluzone 2025-2026Fluzone 2026 Southern HemisphereFluzone 2026-2027Fluzone Quadrivalent 2022-2023Fluzone Quadrivalent 2023-2024Fluzone Quadrivalent 2024 Southern Hemisphere
Available as
0.5 ML · Injection0.5 ML · Prefilled Syringe0.03 MG/ML0.7 ML · Prefilled Syringe158000000 UNT/ML · Nasal Spray
No structured FDA label was available. Use the authoritative links below.
Current FDA labels (DailyMed)
- FLUCELVAX (INFLUENZA A VIRUS A/TASMANIA/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/ARIZONA/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)) INJECTION, SUSPENSION [ASCLEMED USA INC.]
- FLUCELVAX (INFLUENZA A VIRUS A/TASMANIA/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/ARIZONA/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)) INJECTION, SUSPENSION [SPORTPHARM LLC]
- FLUMIST (INFLUENZA VACCINE LIVE INTRANASAL) SPRAY [MEDIMMUNE, LLC]
- FLULAVAL 2026/2027 (INFLUENZA VIRUS VACCINE) SUSPENSION [ID BIOMEDICAL CORPORATION OF QUEBEC]
- FLUAD (INFLUENZA A VIRUS A/MISSOURI/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)) INJECTION, SUSPENSION [SEQIRUS, INC.]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.